182964-02-9Relevant academic research and scientific papers
AMINOIMIDAZOPYRIDINES AS KINASE INHIBITORS
-
Page/Page column 84, (2019/05/22)
Compounds having formula (I), and enantiomers, and diastereomers, stereoisomers, pharmaceutically-acceptable salts thereof, (I) are useful as kinase modulators, including RIPK1 modulation. All the variables are as defined herein.
Imidazoquinazoline derivatives
-
, (2008/06/13)
The present invention relates to imidazoquinazoline derivatives represented by formula (I): STR1 wherein R1 represents hydrogen, substituted or unsubstituted lower alkyl, cycloalkyl, lower alkenyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, R2 and R3 represent independently hydrogen, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroarylalkyl, or substituted or unsubstituted heteroaryl, or R2 and R3 are combined to represent a heterocyclic group containing a nitrogen atom, R4 represents hydrogen or substituted or unsubstituted lower alkyl, X represents O or S, Y represents a single bond or O, n represents 0, 1, 2, or 3, and pharmaceutically acceptable salts thereof.
